Cancer Market Research Reports

RSS Sort By :
TITLE Price Buy Now More options

The global ablation technologies market is estimated to grow at a CAGR of 9.6% from 2014 to 2019. Although mature markets (such as the U.S., Germany, France, and the U.K.) hold larger shares in the ablation technologies market in 2014, the Asia-Pa...

$ 4650


Global Markets Direct's, ‘Uterine Cancer Pipeline Review, H2 2014', provides an overview of the Uterine Cancer's therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Uterine Canc...

$ 2000


Breast cancer is a malignant tumor that originates in the breast tissues. Most breast cancers are invasive tumors that have grown beyond the ducts or lobules of the breast and can metastasize to other parts of the body through the bloodstream and ...

$ 3995


Non-small cell lung cancer occurs when normal cells grow and multiply without control after undergoing a cell transformation. Lung cancer is the leading cause of cancer deaths worldwide, and the incidence of lung cancer is increasing significantly...

$ 2500


Need for early diagnosis and efficient treatment with microbiome therapy for maintaining healthy lifestyle will boost the human microbiome marketThe product segment is expected to account for the largest share of the human ...

$ 4650


The global companion diagnostics market is expected to grow at a CAGR of 22.7% from 2014 to 2019. Factors such as rising need for personalized medicine in cancer treatment, growing adoption of companion diagnostics by the pharmaceutical industry, ...

$ 4650


Global Markets Direct's, ‘Cervical Cancer Pipeline Review, H2 2014', provides an overview of the Cervical Cancer's therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Cervical C...

$ 2000


2014 Opportunities in the Global Cancer Diagnostics Market” is a new seven-country strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends...

$ 32500


“2014 Opportunities in the European Cancer Diagnostics Market” is a new five-country strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in major Eur

$ 19700


“2014 Opportunities in the French Cancer Diagnostics Market” is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the French cancer diagno

$ 6700


“2014 Opportunities in the German Cancer Diagnostics Market” is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the German cancer diagno

$ 6700


“2014 Opportunities in the Italian Cancer Diagnostics Market” is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the Italian cancer diag

$ 6700


“2014 Opportunities in the Japanese Cancer Diagnostics Market” is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the Japanese cancer di

$ 7600


“2014 Opportunities in the Spanish Cancer Diagnostics Market” is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the Spanish cancer diag

$ 6700


“2014 Opportunities in the UK Cancer Diagnostics Market” is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the UK cancer diagnostics ma

$ 6700


“2014 Opportunities in the US Cancer Diagnostics Market” is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the US cancer diagnostics ma

$ 9800


The applications of whole exome sequencing (WES) technologies have witnessed growth in recent years, which can be primarily attributed to the availability of advanced systems as well as the low cost of conducting exome sequencing, as compared with...

$ 4650


The Cancer Monoclonal Antibody Partnering Agreements report provides an understanding and access to the cancer monoclonal antibody partnering deals and agreements entered into by the worlds leading healthcare companies.Trends in cancer...

$ 1995


GBI Research, a leading business intelligence provider, has released its latest research report, Non-Small Cell Lung Cancer Market to 2020 - New Therapies to Enhance Treatment Segmentation and Drive Growth in an Increasingly Competitive Mar...

$ 4995


Global Markets Direct's, ‘Metastatic Colorectal Cancer Pipeline Review, H2 2014', provides an overview of the Metastatic Colorectal Cancer's therapeutic pipeline.This report provides comprehensive information on the therapeutic ...

$ 2000

Live Chat Support
Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441
Subscription Option

Use our subscription option and keep yourself updated about the latest industry analysis reports. We have research reports for over 5000 micro markets; you can access and utilize them at economical budgets.

More about our Subscription option
Email Alerts

Get Email alerts about market research reports from industries and publishers of your interest:

> Live Chat
Live Chat by Comm100